TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • February 28, 2019

SILVER SPRING, MD—The FDA approved the first generic version of Sabril (vigabatrin), a treatment for complex partial seizures. Sabril is manufactured by Lundbeck, Copenhagen, Denmark, and the generic version is manufactured by Teva Pharmaceuticals, Petah Tikva, Israel.